CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 70.65 CNY 1.71% Market Closed
Market Cap: 8.1B CNY
Have any thoughts about
CanSino Biologics Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
CanSino Biologics Inc

Wall Street analysts forecast CanSino Biologics Inc stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CanSino Biologics Inc is 62.57 CNY with a low forecast of 54.54 CNY and a high forecast of 72.11 CNY.

Lowest
Price Target
54.54 CNY
23% Downside
Average
Price Target
62.57 CNY
11% Downside
Highest
Price Target
72.11 CNY
2% Upside
CanSino Biologics Inc Competitors:
Price Targets
000100
Yuhan Corp
19% Downside
LABB
Genomma Lab Internacional SAB de CV
16% Downside
PLTH
Planet 13 Holdings Inc
124% Upside
BSEM
Biostem Technologies Inc
6% Upside
AMPH
Amphastar Pharmaceuticals Inc
38% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
56% Upside
3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd
52% Upside

Revenue
Forecast

Revenue Estimate
CanSino Biologics Inc

The compound annual growth rate of CanSino Biologics Inc's revenue for the next 3 years is 78%.

N/A
Past Growth
78%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
CanSino Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CanSino Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CanSino Biologics Inc's stock price target?
Price Target
62.57 CNY

According to Wall Street analysts, the average 1-year price target for CanSino Biologics Inc is 62.57 CNY with a low forecast of 54.54 CNY and a high forecast of 72.11 CNY.

What is CanSino Biologics Inc's Revenue forecast?
Projected CAGR
78%

The compound annual growth rate of CanSino Biologics Inc's revenue for the next 3 years is 78%.

Back to Top